Member Exclusive

Biotech Co. Submits CTA for its 2nd Trial Launching in 2015

RepliCel's autologous cell therapy, RCS-01, to be investigated as a potential treatment for aged and UV-damaged skin.

Go to the profile of Lee Buckler
Feb 23, 2015

Please sign in or register for FREE

Register to RegMedNet

RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.


No comments yet.